S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?

Veeva Systems (VEEV) Stock Price, News & Analysis

$233.53
+0.85 (+0.37%)
(As of 03/27/2024 ET)
Today's Range
$231.89
$234.92
50-Day Range
$201.81
$234.79
52-Week Range
$160.21
$236.90
Volume
586,299 shs
Average Volume
1.05 million shs
Market Capitalization
$37.60 billion
P/E Ratio
72.52
Dividend Yield
N/A
Price Target
$234.90

Veeva Systems MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.65 Rating Score
Upside/​Downside
0.6% Upside
$234.90 Price Target
Short Interest
Healthy
1.53% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.79
Upright™ Environmental Score
News Sentiment
0.69mentions of Veeva Systems in the last 14 days
Based on 20 Articles This Week
Insider Trading
Selling Shares
$6.22 M Sold Last Quarter
Proj. Earnings Growth
14.36%
From $4.11 to $4.70 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.44 out of 5 stars

Computer And Technology Sector

84th out of 588 stocks

Prepackaged Software Industry

21st out of 192 stocks

VEEV stock logo

About Veeva Systems Stock (NYSE:VEEV)

Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and data solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process. In addition, it offers professional and support services, including implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; data migration and systems integrations technical consulting services; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

VEEV Stock Price History

VEEV Stock News Headlines

Trending Stocks Sent To You In Real Time
Sign up today and get instant access to our next stock alert! You do not want to miss out on this next pick! Our stock picks have been known to soar!
Veeva Systems: A Jewel In Transition
Veeva Systems (VEEV) Fell on Revenue Guidance
Altcoin FRENZY Alert…
Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days…
Why the AI Gold Rush Is More Than Hype
SAM Apr 2024 400.000 call
SMCI Mar 2024 1145.000 call
VEEV Apr 2024 200.000 call
SMCI Jan 2025 1780.000 put
SMCI Mar 2024 1235.000 put
Bull of the Day: Veeva Systems Inc. (VEEV)
Veeva price target raised by $18 at KeyBanc, here's why
See More Headlines
Receive VEEV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Veeva Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/29/2024
Today
3/27/2024
Next Earnings (Estimated)
5/29/2024
Fiscal Year End
1/31/2025

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Employees
6,744
Year Founded
2007

Price Target and Rating

Average Stock Price Target
$234.90
High Stock Price Target
$270.00
Low Stock Price Target
$160.00
Potential Upside/Downside
+0.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.65
Research Coverage
20 Analysts

Profitability

Net Income
$525.71 million
Pretax Margin
23.55%

Debt

Sales & Book Value

Annual Sales
$2.36 billion
Cash Flow
$2.99 per share
Book Value
$23.48 per share

Miscellaneous

Free Float
143,336,000
Market Cap
$37.60 billion
Optionable
Optionable
Beta
0.74

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Should I Buy Veeva Systems Stock? VEEV Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Veeva Systems was last updated on Monday, March 25, 2024 at 11:06 AM.

Pros

Here are some ways that investors could benefit from investing in Veeva Systems Inc.:

  • Veeva Systems provides cloud-based software tailored for the life sciences industry, offering solutions like Veeva Commercial Cloud and Veeva Vault PromoMats, catering to the specific needs of pharmaceutical and biotechnology companies.
  • The company's suite of applications, including Veeva Vault Clinical and Veeva Vault Safety, addresses critical functions in the clinical, regulatory, quality, and safety domains, enhancing operational efficiency and compliance.
  • Veeva Systems' focus on customer relationship management (CRM) through Veeva CRM and data solutions like Veeva OpenData and Veeva Link enables pharmaceutical companies to optimize customer interactions and generate real-time intelligence.
  • With Veeva Compass offering de-identified and longitudinal patient data for the United States, the company provides valuable insights for decision-making and strategic planning within the healthcare sector.
  • Considering the recent positive market sentiment towards Veeva Systems Inc., reflected in its stock price performance, investors may find potential growth opportunities in the company's innovative software solutions tailored for the life sciences industry.

Cons

Investors should be bearish about investing in Veeva Systems Inc. for these reasons:

  • While Veeva Systems offers specialized software solutions for the life sciences industry, the competitive landscape in the sector is intense, with other tech companies vying for market share, potentially impacting Veeva's growth trajectory.
  • Market volatility and regulatory changes within the healthcare industry can pose risks to Veeva Systems' operations and financial performance, affecting investor confidence in the company's long-term stability.
  • Investors should carefully assess Veeva Systems' revenue diversification and customer retention strategies to gauge the company's ability to sustain growth and navigate challenges in the evolving life sciences market.
  • Fluctuations in macroeconomic conditions and global healthcare spending trends may influence Veeva Systems' business prospects and profitability, requiring investors to monitor industry dynamics closely.
  • Considering the dynamic nature of the technology sector and the need for continuous innovation, investors should evaluate Veeva Systems' research and development efforts to ensure the company remains competitive and relevant in the long run.

VEEV Stock Analysis - Frequently Asked Questions

Should I buy or sell Veeva Systems stock right now?

20 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Veeva Systems in the last year. There are currently 1 sell rating, 5 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" VEEV shares.
View VEEV analyst ratings
or view top-rated stocks.

What is Veeva Systems' stock price target for 2024?

20 Wall Street research analysts have issued 1-year price objectives for Veeva Systems' stock. Their VEEV share price targets range from $160.00 to $270.00. On average, they predict the company's share price to reach $234.90 in the next year. This suggests a possible upside of 0.6% from the stock's current price.
View analysts price targets for VEEV
or view top-rated stocks among Wall Street analysts.

How have VEEV shares performed in 2024?

Veeva Systems' stock was trading at $192.52 at the beginning of the year. Since then, VEEV stock has increased by 21.3% and is now trading at $233.53.
View the best growth stocks for 2024 here
.

When is Veeva Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 29th 2024.
View our VEEV earnings forecast
.

How were Veeva Systems' earnings last quarter?

Veeva Systems Inc. (NYSE:VEEV) posted its quarterly earnings data on Thursday, February, 29th. The technology company reported $0.92 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.81 by $0.11. The technology company had revenue of $630.62 million for the quarter, compared to the consensus estimate of $620.75 million. Veeva Systems had a net margin of 22.24% and a trailing twelve-month return on equity of 11.59%.

What guidance has Veeva Systems issued on next quarter's earnings?

Veeva Systems issued an update on its first quarter 2025 earnings guidance on Thursday, February, 29th. The company provided earnings per share (EPS) guidance of 1.420-1.430 for the period, compared to the consensus EPS estimate of 1.270. The company issued revenue guidance of $640.0 million-$643.0 million, compared to the consensus revenue estimate of $645.8 million.

What is Peter Gassner's approval rating as Veeva Systems' CEO?

202 employees have rated Veeva Systems Chief Executive Officer Peter Gassner on Glassdoor.com. Peter Gassner has an approval rating of 82% among the company's employees.

What other stocks do shareholders of Veeva Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Veeva Systems investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), PayPal (PYPL), Shopify (SHOP), Walt Disney (DIS), Adobe (ADBE), Netflix (NFLX), Trade Desk (TTD) and Block (SQ).

Who are Veeva Systems' major shareholders?

Veeva Systems' stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (8.17%), Vanguard Group Inc. (8.17%), Artisan Partners Limited Partnership (4.09%), Price T Rowe Associates Inc. MD (3.61%), Massachusetts Financial Services Co. MA (1.35%) and Van ECK Associates Corp (1.10%). Insiders that own company stock include Alan Mateo, Brent R Bowman, Eleni Nitsa Zuppas, Frederic Lequient, Jonathan Faddis, Joseph Christopher Hays, Mary Lynne Hedley, Matthew J Wallach, Matthew J Wallach, Michele O'connor, Paul Edward Chamberlain, Paul J Sekhri, Peter P Gassner, Ronald E F Codd, Steven L Fasman, Thomas D Schwenger and Timothy S Cabral.
View institutional ownership trends
.

How do I buy shares of Veeva Systems?

Shares of VEEV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Veeva Systems have any subsidiaries?
The following companies are subsidiares of Veeva Systems: AdvantageMS, Learnaboutgmp, Physicians World, Selligy, Veeva Crossix, Veeva RTSM, Veracity Logic, and Zinc Ahead Ltd.
Read More
This page (NYSE:VEEV) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners